Merck Patent Gmbh

Laboratoire Theramex

Nathalie Adje

Stéphane Yvon

Didier Roche

Francis Contard

Valérie Guyard-Dangremont

Michel Brunet

Denis Carniato

Jean-Claude Pascal

Daniel Guerrier

Yves Bonhomme

Jean Lafay

Jean-Jacques Zeiller

Jean Jacques Zeiller

Gérard Ferrand

Paule Bonnet

Catherine Vidal

Remi Delansorne

Compounds of the formula (I): in which A, R, R, X, Y and Z are defined in the description, the processes for the preparation of these compounds, the uses thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, and the pharmaceutical compositions comprising them. 

Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions them, and therapeutic uses thereof

Compounds of the formula (1) in which R, R, X, Y and Z are as defined in the description, the processes for the preparation of these compounds, the uses thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, and the pharmaceutical compositions comprising them. 

Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof

Compounds of the formula (1): in which A, R, Rand Rare as defined in the description, the processes for the preparation of these compounds, the uses thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, and the pharmaceutical compositions comprising them. 

[object Object]

Disclosed are Compounds of formula I  And methods of use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes.

Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia

1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them

Growing community of inventors

Genas, France

Nathalie Adje